Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · IEX Real-Time Price · USD
0.642
-0.018 (-2.79%)
At close: May 2, 2024, 3:58 PM
0.649
+0.007 (1.14%)
After-hours: May 2, 2024, 7:37 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $16.23 million as of May 2, 2024. Its market cap has decreased by -34.28% in one year.
Market Cap
16.23M
Enterprise Value
-4.59M
1-Year Change
-34.28%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $398.90M to $16.23M, a decrease of -95.93%. That is a compound annual growth rate of -25.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 1, 2024 | 13.90M | - |
Apr 30, 2024 | 13.90M | 2.96% |
Apr 29, 2024 | 13.50M | 3.05% |
Apr 26, 2024 | 13.10M | -1.50% |
Apr 25, 2024 | 13.30M | -1.48% |
Apr 24, 2024 | 13.50M | -3.57% |
Apr 23, 2024 | 14.00M | -0.71% |
Apr 22, 2024 | 14.10M | - |
Apr 19, 2024 | 14.10M | -3.42% |
Apr 18, 2024 | 14.60M | 1.39% |
Apr 17, 2024 | 14.40M | -1.37% |
Apr 16, 2024 | 14.60M | -3.31% |
Apr 15, 2024 | 15.10M | 0.67% |
Apr 12, 2024 | 15.00M | -9.09% |
Apr 11, 2024 | 16.50M | -1.20% |
Apr 10, 2024 | 16.70M | 3.09% |
Apr 9, 2024 | 16.20M | -1.82% |
Apr 8, 2024 | 16.50M | -2.94% |
Apr 5, 2024 | 17.00M | -3.41% |
Apr 4, 2024 | 17.60M | -2.22% |
Apr 3, 2024 | 18.00M | -13.88% |
Apr 2, 2024 | 20.90M | -0.48% |
Apr 1, 2024 | 21.00M | -0.94% |
Mar 28, 2024 | 21.20M | 3.92% |
Mar 27, 2024 | 20.40M | 7.94% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Talphera | 17.82M |
Vincerx Pharma | 17.77M |
Streamline Health Solutions | 17.61M |
CareCloud | 17.41M |
QT Imaging Holdings | 16.94M |
Avalo Therapeutics | 16.63M |
FSD Pharma | 16.57M |
NeuroBo Pharmaceuticals | 16.53M |